Composition and light emitting device using the same

US10141514B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10141514-B2
Application numberUS-201515303920-A
CountryUS
Kind codeB2
Filing dateMar 30, 2015
Priority dateApr 18, 2014
Publication dateNov 27, 2018
Grant dateNov 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition is provided containing: a phosphorescent compound having an emission spectrum whose maximum peak wavelength is between 380 nm or more and less than 495 nm, having no dendron and represented by formula (1′); two or more phosphorescent compounds having an emission spectrum whose maximum peak wavelength is between 495 nm or more and less than 750 nm and having a dendron; and a compound represented by formula (H-1). In formula (1′) M represents an iridium atom or the like, n 1 represents an integer of 1 or more, n 2 represents an integer of 0 or more, E 1 and E 2 represent a carbon atom or the like, the ring R 1′ represents a diazole ring, the ring R 2 represents a 6-membered aromatic hydrocarbon ring or the like, and A 1 -G 1 -A 2 represents an anionic bidentate ligand.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition comprising a phosphorescent compound (B) having an emission spectrum whose maximum peak wavelength is from 380 nm to less than 495 nm and having no dendron represented by the formula (D-A) or (D-B), wherein the emission spectrum is obtained by measuring the PL spectrum of a dilute solution comprising the phosphorescent compound (B) and an organic solvent at room temperature, two or more phosphorescent compounds (DGR) having an emission spectrum whose maximum peak wavelength is from 495 nm to less than 750 nm and having a dendron represented by the formula (D-A) or (D-B′), wherein the emission spectrum is obtained by measuring the PL spectrum of a dilute solution comprising the phosphorescent compound (DGR) and an organic solvent at room temperature, and a compound represented by the formula (H-1), wherein the phosphorescent compound (B) is a phosphorescent compound represented by the formula (1′), each of the two or more phosphorescent compounds (DGR) is a phosphorescent compound represented by the formula (2), and at least one of the two or more phosphorescent compounds (DGR) is a phosphorescent further compound represented by the formula (2-A1), (2-A2), (2-A3), or (2-A4), and a ratio of the content of the two or more phosphorescent compounds (DGR) to the content of the phosphorescent compound (B) is 0.1 to 10 parts by weight to 100 parts by weight: wherein m DA1 , m DA2 and m DA3 each independently represent an integer of 0 or more, G DA represents a nitrogen atom, an aromatic hydrocarbon group or a heterocyclic group and these groups each optionally have a substituent, Ar DA1 , Ar DA2 and Ar DA3 each independently represent an arylene group or a divalent heterocyclic group and these groups each optionally have a substituent, and when a plurality of Ar DA1 , Ar DA2 and Ar DA3 are present, they may be the same or different at each occurrence, and T DA represents an aryl group or a monovalent heterocyclic group and these groups each optionally have a substituent, and the plurality of T DA may be the same or different: wherein m DA4 , m DA5 , m DA6 and m DA7 each independently represent an integer of 0 or more, the plurality of G DA may be the same or different, Ar DA1 , Ar DA2 , Ar DA3 , Ar DA4 , Ar DA5 , Ar DA6 and Ar DA7 each independently represent an arylene group or a divalent heterocyclic group and these groups each optionally have a substituent, and when a plurality of Ar DA1 , Ar DA2 , Ar DA3 , Ar DA4 , Ar DA5 , Ar DA6 and Ar DA7 are present, they may be the same or different at each occurrence; wherein G DA1 , G DA2 and G DA3 each independently represent a nitrogen atom,anaromatic hydrocarbon group or a heterocyclic group and these groups each optionally have a substituent, and m DA2 is an integer of 1 or more when G DA1 and G DA2 are each a nitrogen atom, m DA3 is an integer of 1 or more when G DA1 and G DA3 are each a nitrogen atom; wherein Ar H1 and Ar H2 each independently represent an aryl group or a monovalent heterocyclic group and these groups each optionally have a substituent, n H1 represents 1, n H2 represents 0 or 1, and a plurality of n H2 may be the same or different, n H3 represents 1, L H1 represents a divalent heterocyclic group represented by the formula (AA-10), (AA-11), (AA-12), (AA-13), (AA-14), (AA-15), (AA-33) or (AA-34), L H2 represents a group represented by -N(-L H21 - R H21 )-, and when a plurality of L H2 are present, they may be the same or different, and L H21 represents a single bond, an arylene group or a divalent heterocyclic group and these groups each optionally have a substituent, and R H21 represents a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group or a monovalent heterocyclic group and these groups each optionally have a substituent: wherein R represents a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group or a monovalent heterocyclic group, and a plurality of R may be the same or different: wherein M represents a ruthenium atom, a rhodium atom, a palladium atom, an iridium atom or a platinum atom, n 1 represents an integer of 1 or more, n 2 represents an integer of 0 or more, and n 1 +n 2 is 2 or 3, and n 1 +n 2 is 3 when M is a ruthenium atom, a rhodium atom or an iridium atom, while n 1 +n 2 is 2 when M is a palladium atom or a platinum atom, E 1 and E 2 each independently represent a carbon atom or a nitrogen atom, and at least one of E 1 and E 2 is a carbon atom, the ring R 1′ represents a diazole ring and this diazole ring optionally has a substituent, and when a plurality of substituents are present, they may be the same or different and may form a ring together with atoms to which they are attached, and when a plurality of the rings R 1′ are present, they may be the same or different, the ring R 2 represents a 5-membered or 6-membered aromatic hydrocarbon ring or a 5-membered or 6-membered aromatic heterocyclic ring and these rings each optionally have a substituent, and when a plurality of substituents are present, they may be the same or different and may form a ring together with atoms to which they are attached, and when a plurality of the rings R 2 are present, they may be the same or different, and E 2 is a carbon atom when the ring R 2 is a 6-membered aromatic heterocyclic ring, the substituent which the ring R 1′ optionally has and the substituent which the ring R 2 optionally has may form a ring together with atoms to which they are attached, and A 1 -G 1 -A 2 represents an anionic bidentate ligand, A 1 and A 2 each independently represent a carbon atom, an oxygen atom or a nitrogen atom and together may constitute a ring, G 1 represents a single bond or an atomic group constituting the bidentate ligand together with A 1 and A 2 , and when a plurality of A 1 -G 1 -A 2 are present, they may be the same or different: wherein M represents a ruthenium atom, a rhodium atom, a palladium atom, an iridium atom or a platinum atom, n 3 represents an integer of 1 or more, n 4 represents an integer of 0 or more, and n 3 +n 4 is 2 or 3, and n 3 +n 4 is 3 when M is a ruthenium atom, a rhodium atom or an iridium atom, while n 3 +n 4 is 2 when M is a palladium atom or a platinum atom, E 4 represents a carbon atom or a nitrogen atom, the ring R 3 represents a 6-membered aromatic heterocyclic ring and this ring optionally has a substituent, and when a plurality of substituents are present, they may be the same or different and may form a ring together with atoms to which they are attached, and when a plurality of the rings R 3 are present, they may be the same or different, the ring R 4 represents a 5-membered or 6-membered aromatic hydrocarbon ring or a 5-membered or 6-membered aromatic heterocyclic ring and these rings each optionally have a substituent and when a plurality of substituents are present, they may be the same or different and may form a ring together with atoms to which they are attached, and when a plurality of the rings R 4 are present, they may be the same or different, and E 4 is a carbon atom

Assignees

Inventors

Classifications

  • fluorene-based, e.g. fluorene, indenofluorene, or spirobifluorene · CPC title

  • crosslinking · CPC title

  • non-luminescent particle coatings or suspension media · CPC title

  • Cross-linked structures · CPC title

  • Side-chains having aromatic units · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10141514B2 cover?
A composition is provided containing: a phosphorescent compound having an emission spectrum whose maximum peak wavelength is between 380 nm or more and less than 495 nm, having no dendron and represented by formula (1′); two or more phosphorescent compounds having an emission spectrum whose maximum peak wavelength is between 495 nm or more and less than 750 nm and having a dendron; and a compou…
Who is the assignee on this patent?
Sumitomo Chemical Co
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).